The ALS Therapy Development Institute announced that the annual Race 4 Research 5K and Walk will be held on Sunday, May 7, 2017 in Technology Square in Cambridge, MA. The Race 4 Research features a 5K road race and four-mile walk followed by an after-party with refreshments courtesy of local restaurants, breweries and other vendors.

An informal awards ceremony will be held after the race where top three male and female finishers will receive cash prizes. This year, all participants are encouraged to dress in nerdy costumes and prizes will be awarded to best dressed. All proceeds from the event will benefit the ALS Therapy Development Institute, a nonprofit biotech whose scientists actively discover and develop treatments and a cure for amyotrophic lateral sclerosis (ALS). 

“As scientists, we at ALS TDI are in a race against time to find an effective drug to slow or stop the progression of ALS. The funds raised by families and individuals at the Race 4 Research each year have been significant in helping to push promising treatments, including AT-1501, toward clinical trials. We hope that more runners and walkers than ever will turn up at Cambridge this year to raise vital funding for the development of treatments in ALS.” says Steve Perrin, Ph.D., CEO and Chief Scientific Officer at the ALS Therapy Development Institute.

The Race 4 Research will open registration at 8:30 AM. The four-mile walk will begin promptly at 9:30 AM and the 5K will begin at 10.00 AM. Lab tours of the ALS Therapy Development Institute’s facility will also be available to participants beginning at noon.

Sponsors for this year's Race 4 Research include MT Pharma America, patientslikeme, CrossCountry Consulting, with in-kind donations from Alexandria Real EstateBaiCatalyst Cafe, Nift, Noosa YogurtPoland Spring and Portico Brewing Company.

To participate, donate or learn more about the Race 4 Research 5K and Walk, visit  

About the ALS Therapy Development Institute

The ALS Therapy Development Institute and its scientists actively discover and develop treatments for ALS. The Institute is the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Led by people with ALS and drug development experts, ALS TDI understands the urgent need to slow and stop this horrible disease. Based in Cambridge, MA, the Institute has served as one of the leaders in sharing data and information with academic and ALS research organizations, people with ALS and their families. For more information, visit

Media Contact:  Colette O’Neill, ALS Therapy Development Institute, 617-441-7269,